Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Pfizer Ventures

Profile and portfolio

Parent PfizerHQ New York, United StatesFounded 2004

Pfizer Ventures is the corporate venture arm of Pfizer, a pharmaceutical and biotech company. It was founded in 2004 and is based in New York, United States. It invests from seed to late stage. Sectors it names: biotech and life sciences.

Companies backedS2
121

Every figure links to its source

Snapshot

Investment stage: Seed to Late stage
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Late stage
SectorsBiotech and life sciences
GeographyNorth America, Europe, Asia, Middle East and Africa (Portfolio companies by region, from the firm's portfolio page)
OfficesNew York, United States

Sources: S1 Pfizer Ventures page (pfizer.com); S2 Pfizer Ventures portfolio page (active and former tabs).

Graphic 1 of 3

Investment stage: Seed to Late stage

Sources: S1 Pfizer Ventures page (pfizer.com); S2 Pfizer Ventures portfolio page (active and former tabs).

Download:Report a correction
Investments closed by outcome
Data behind this graphic
Data behind this graphic
ItemCompaniesShare
Exited5052.1%
Active4647.9%

Status as the firm tags it

Sources: S2 Pfizer Ventures portfolio page (active and former tabs).

Graphic 2 of 3

Investments closed by outcome

Sources: S2 Pfizer Ventures portfolio page (active and former tabs).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Companies backed121companiesStated by the firmS2
Companies on the firm's portfolio page121companiesCounted from the firm's own listS2

Sources: S2 Pfizer Ventures portfolio page (active and former tabs).

Graphic 3 of 3

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S2 Pfizer Ventures portfolio page (active and former tabs).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
New York, United States

Portfolio companies by regionS1S2

  • North America91 · 76%
  • Europe24 · 20%
  • Middle East and Africa3 · 3%
  • Asia2 · 2%

Portfolio companies by region, from the firm's portfolio page

LeadersS6S7S8S9S1

Pfizer Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companyPfizer (NYSE: PFE)Single sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2004Single sourceS3
HeadquartersNew York, United StatesSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Companies backed121Single sourceS2
People on the team page12Single sourceS1
StagesSeed, Series A, Series B, Series C+, Late stageSingle sourceS1

Portfolio

The firm's portfolio page lists 121 companies: 50 exited, 46 active.S2

Companies by status on the firm's list. Status as the firm tags itS2
TagCompaniesShare
Exited5041.3%
Active4638%

Shared portfolio with other corporate VCs

31 companies on the Pfizer Ventures portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
M Ventures5FoRx Therapeutics, Storm Therapeutics, TRIMTECH Therapeutics, Enara Bio, TwoStep Therapeutics
Leaps by Bayer4Mozart Therapeutics, Capstan Therapeutics, ReCode Therapeutics, Pyxis Oncology
Novartis Venture Fund4FoRx Therapeutics, Mediar Therapeutics, Anaveon, Artios Pharma
Sanofi Ventures4Normunity, ReCode Therapeutics, Kymera Therapeutics, Yumanity Therapeutics
Taiho Ventures3Normunity, Storm Therapeutics, NextCure
Ono Venture Investment2Mozart Therapeutics, Mediar Therapeutics
Merck Global Health Innovation Fund2Saama, Strata Oncology
Astellas Venture Management2DEM BioPharma, eFFECTOR Therapeutics
Roche Venture Fund2Mission Therapeutics, Second Genome
GV2Nimbus Therapeutics, Oblenio Bio
JJDC2Nucleome Therapeutics, TRexBio
MRL Ventures Fund1Mozart Therapeutics

Companies backed by the most corporate VCs

Every company on the Pfizer Ventures list

121 companies, as listed on the firm's own website: 50 exited, 46 active, 25 listed.S2 Read the firm's list.

Exited 50

  • 4D Molecular Therapeutics
  • Ablexis
  • Aquinox Pharmaceuticals
  • Avid Radiopharmaceuticals
  • BioAtla
  • BioNTech
  • Bolt Biotherapeutics
  • Capstan Therapeutics
  • Clovis Oncology
  • Cortexyme
  • CytomX Therapeutics
  • DVS Sciences
  • eFFECTOR Therapeutics
  • Eiger Biopharmaceuticals
  • Evolution Benefits
  • Flexion Therapeutics
  • G-CON Manufacturing
  • Genomic Health
  • Handylab
  • HD Biosciences
  • Imara
  • ImCheck Therapeutics
  • Interius BioTherapeutics
  • Jnana Therapeutics
  • Kymera Therapeutics
  • Lodo Therapeutics
  • M2S
  • Mersana Therapeutics
  • Merus
  • miRNA Therapeutics
  • Mitokinin
  • Morphic Therapeutic
  • NeuMoDx Molecular
  • Neuronetics
  • NextCure
  • NovoCure
  • Petra Pharma
  • Pyxis Oncology
  • RaNA Therapeutics
  • Rhythm Pharmaceuticals
  • SpringWorks Therapeutics
  • superDimension
  • SupplyScape
  • TetraLogic Pharmaceuticals
  • Therachon
  • Vaccine Company
  • VectivBio
  • Vtesse
  • Yumanity Therapeutics
  • Ziarco Pharma

Active 46

  • Anaveon
  • Aquinnah Pharmaceuticals
  • Arrakis Therapeutics
  • Artios Pharma
  • Autifony Therapeutics
  • Autobahn Therapeutics
  • BioGraph 55
  • Cartography Biosciences
  • Crossbow Therapeutics
  • Curve Therapeutics
  • DEM Biopharma
  • Enara Bio
  • Enlaza Therapeutics
  • Enodia Therapeutics
  • EvolveImmune Therapeutics
  • Flare Therapeutics
  • FoRx Therapeutics
  • Greywolf Therapeutics
  • Immunocodex
  • ImmunOs Therapeutics
  • Incendia Therapeutics
  • Kestrel Therapeutics
  • Levicept
  • Mediar Therapeutics
  • MindImmune Therapeutics
  • Mission Therapeutics
  • Montis Biosciences
  • Mozart Therapeutics
  • National Resilience
  • Nimbus Therapeutics
  • Normunity
  • Nucleome Therapeutics
  • Oblenio Bio
  • OTR Therapeutics
  • Palleon Pharma
  • Prescriber Point
  • ReCode Therapeutics
  • RefleXion Medical
  • Saama Technologies
  • Storm Therapeutics
  • Strata Oncology
  • TRex Bio
  • Triana Biomedicines
  • TRIMTECH Therapeutics
  • TwoStep Therapeutics
  • Vibrant Therapeutics

Listed 25

  • Accelerator
  • Adapsyn Bioscience
  • AMRA Medical
  • Anjarium Biosciences
  • Arkuda Therapeutics
  • Aureon Laboratories
  • Aviir
  • Blade Therapeutics
  • BlueLight Therapeutics
  • Complexa
  • Cydan & Cydan II
  • DIR Technologies
  • Entelos
  • Epic Sciences
  • Ixchelsis
  • Magnolia Neurosciences
  • Metabomed
  • NexImmune
  • Nodality
  • Quartet Medicine
  • Second Genome
  • Simcha Therapeutics
  • System1 Biosciences
  • Triplet Therapeutics
  • VitaDAO

For founders

ItemWhat the firm saysSource
StagesSeed, Series A, Series B, Series C+, Late stageS1
Check sizeUSD 5M to USD 20MS1
Leads roundsYesS1
Contact formwww.pfizer.com/about/partners/submit-your-opportunitiesS5

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeYearAcquirer or exchangeSource
Capstan TherapeuticsAcquisition2025AbbVieS3
Imcheck TherapeuticsAcquisition2025IpsenS3
Interius BiotherapeuticsAcquisition2025Gilead/KiteS3

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2025-10-01Cartography BiosciencesSeries BUSD 67MYesS3
2025-06-01OTR TherapeuticsSeries AUSD 100MNoS3
2025-03-01TRIMTECH TherapeuticsSeedUSD 31MNoS3

Fund vehicles

VehicleSizeYearSource
China-based venture vehicle with a local VC groupNot published2025S3

Investments by year

YearNewSource
20247S4
20259S3

History

  1. Pfizer Ventures founded.S3
  2. China-based venture vehicle established with a local VC group; nine new investments.S3

About Pfizer

ItemDetailSource
Listed asNYSE: PFES12
HeadquartersUnited StatesS1

Official pages

Read the firm's own pages for current information.

  • Website www.pfizer.com/partners/venture-investments
  • Portfolio www.pfizer.com/partners/venture-investments/our-portfolio

Sources

  1. S1Pfizer Ventures page (pfizer.com)Firm
  2. S2Pfizer Ventures portfolio page (active and former tabs)Firm
  3. S3Pfizer Ventures 2025 in Review brochure (PDF)Firm
  4. S4Pfizer Ventures 2024 in Review brochure (PDF)Firm
  5. S5Pfizer: Submit your opportunitiesFirm
  6. S6Pfizer: Michael Diem bio pageFirm
  7. S7Pfizer: Rana Al-Hallaq bio pageFirm
  8. S8Pfizer: Irena Melnikova bio pageFirm
  9. S9Pfizer: Christopher O'Donnell bio pageFirm
  10. S10Global Venturing: Barbara Dalton retirement (29 Dec 2023)Press
  11. S12SEC EDGAR: Pfizer Inc (CIK 78003)Filing
  12. S13Wayback: Pfizer Ventures portfolio capture 18 Jun 2026Firm
  13. S14FundingWatcher corporate venture capital listThird-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Pfizer Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.